Sign In
Buy INBS
$1.96
-0.0200 (-1.01%)
At Close: Aug 10, 2026
HealthEquity (NASDAQ:HQY) & Intelligent Bio Solutions (NASDAQ:INBS) Head to Head Comparison
01:46am, Monday, 02'nd Mar 2026
HealthEquity (NASDAQ: HQY - Get Free Report) and Intelligent Bio Solutions (NASDAQ: INBS - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two busines
Successful delivery in partnership with Syrma Johari validates manufacturing scale, strengthens commercial readiness, and supports planned U.S. market entry in 2026
Initial 13-site deployment with UK subsidiary of global construction firm employing 35,600 employees across 50+ countries, validates commercial scalability and ROI of INBS's fingerprint drug testing t
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year
08:30am, Thursday, 12'th Feb 2026
First half fiscal 2026 revenue surpasses $2 million, up 36% year-over-year Reader sales more than double to 104% year-over-year for the second quarter, demonstrating razor-razorblade model momentum
Expected record fiscal second quarter revenue increase driven by expanding customer base and strong growth across all product categories Reader sales expected to post year-over-year growth of more tha
Short Interest in Intelligent Bio Solutions Inc. (NASDAQ:INBS) Increases By 187.3%
03:16am, Saturday, 31'st Jan 2026
Intelligent Bio Solutions Inc. (NASDAQ: INBS - Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 369
Clinical studies designed to support FDA clearance and planned commercial launch into the world's largest drug screening market Company anticipates full data analysis by the end of March 2026; data
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
05:00pm, Friday, 02'nd Jan 2026
NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive te
INBS Stock Surges 132.4% on New Manufacturing Partnership
12:40pm, Friday, 02'nd Jan 2026
Intelligent Bio Solutions' stock jumps after a new manufacturing partnership aimed at cutting costs, boosting margins and scaling production ahead of U.S. expansion.
U.S. stock futures rose on the first trading day of the year on Friday after missing the Santa Claus rally over the truncated week. Futures of major benchmark indices were higher. The Santa Claus trad
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
05:20pm, Wednesday, 31'st Dec 2025
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive te
Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts
12:12pm, Wednesday, 31'st Dec 2025
Intelligent Bio Solutions Inc. (NASDAQ: INBS) stock is trading higher on Wednesday, with a session volume of 48.13 million compared to the average volume of 34.79 thousand, as per data from Benzinga P
Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins
08:45am, Wednesday, 31'st Dec 2025
Partnership with Syrma Johari Medtech, a globally recognized medical device engineering and manufacturing organization, expands INBS' global manufacturing capacity, strengthens supply-chain resilience
Intelligent Bio Solutions (NASDAQ:INBS) Trading Down 2.8% – Here’s What Happened
02:27am, Saturday, 27'th Dec 2025
Intelligent Bio Solutions Inc. (NASDAQ: INBS - Get Free Report)'s stock price traded down 2.8% during mid-day trading on Friday. The company traded as low as $4.55 and last traded at $4.84. 17,250 sha
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing technologies Alliance positions INBS to e
